Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda.

MLA

Mwebe, Sandra Z., et al. “Impact of Hematocrit on Point-of-Care C-Reactive Protein-Based Tuberculosis Screening among People Living with HIV Initiating Antiretroviral Therapy in Uganda.” Diagnostic Microbiology and Infectious Disease, vol. 99, no. 3, Mar. 2021, p. 115281. EBSCOhost, https://doi.org/10.1016/j.diagmicrobio.2020.115281.

APA

Mwebe, S. Z., Yoon, C., Asege, L., Nakaye, M., Katende, J., Andama, A., Cattamanchi, A., & Semitala, F. C. (2021). Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda. Diagnostic Microbiology and Infectious Disease, 99(3), 115281. https://doi.org/10.1016/j.diagmicrobio.2020.115281

Chicago

Mwebe, Sandra Z, Christina Yoon, Lucy Asege, Martha Nakaye, Jane Katende, Alfred Andama, Adithya Cattamanchi, and Fred C Semitala. 2021. “Impact of Hematocrit on Point-of-Care C-Reactive Protein-Based Tuberculosis Screening among People Living with HIV Initiating Antiretroviral Therapy in Uganda.” Diagnostic Microbiology and Infectious Disease 99 (3): 115281. doi:10.1016/j.diagmicrobio.2020.115281.